Ftse Mib
38.996,43
0,88%
DAX
23.154,57
0,94%
S&P 500
5.675,12
0,64%
NASDAQ
17.808,66
0,31%
Bitcoin
84.093,64
1,87%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Bausch plus Lomb Corporation (BLCO) Bausch plus Lomb Corporation (BLCO) Notizie

Bausch plus Lomb Corporation

BLCO
15,40
0,05 (0,33%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 21:03:41
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/3/202512:00BWBausch + Lomb Launches Arise™ Orthokeratology Lens System in..
03/3/202522:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202522:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202522:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202522:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202522:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/2/202513:01EDGAR2Form 8-K - Current report
19/2/202512:58BWBausch + Lomb Announces Fourth-Quarter and Full-Year 2024..
06/2/202513:00BWBausch + Lomb Provides Update on Potential Sale
22/1/202513:00BWBausch + Lomb Will Release Fourth-Quarter and Full-Year 2024..
13/1/202513:00BWBausch + Lomb Bolsters Pipeline with Acquisition of Whitecap..
13/1/202512:00BWBausch + Lomb Launches enVista Aspire™ Intermediate..
07/1/202513:00BWBausch + Lomb and Glaucoma Research Foundation Launch Second..
02/1/202513:00BWBausch + Lomb to Participate in the 43rd Annual J.P. Morgan..
26/12/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202413:00BWBausch + Lomb Responds to Rumors of a Potential Sale
11/12/202412:59BWBausch + Lomb Acquires Elios Vision, Significantly Enhances..
14/11/202413:00BWBausch + Lomb Reports More Than 94 Million Units of Contact..
01/11/202421:27EDGAR2Form 8-K - Current report
30/10/202421:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/10/202412:04EDGAR2Form 8-K - Current report
30/10/202412:00BWBausch + Lomb Announces Third-Quarter 2024 Results
14/10/202413:00BWBausch + Lomb Receives FDA Approval for enVista® Envy™ Full..
09/10/202414:00BWBausch + Lomb Will Release Third-Quarter 2024 Financial..
01/10/202413:00BWBausch + Lomb Launches Opal™ Digital Marketplace in the..
17/9/202412:42IHMARKETNEWSInvestors Anticipate Retail Sales Data and Fed Decision; Oil..
06/8/202423:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202422:48EDGAR2Form S-8 - Securities to be offered to employees in employee..
01/8/202422:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/7/202413:06EDGAR2Form 8-K - Current report
31/7/202413:00BWBausch + Lomb Announces Second-Quarter 2024 Results
30/7/202401:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/7/202401:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/7/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/7/202418:05BWBausch + Lomb Will Release Second-Quarter 2024 Financial..
08/7/202413:00BWMillions of Americans Experience Dry Eye Symptoms, Yet New..
18/6/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202413:00BWBausch + Lomb Announces Presentation of New Data at the..
10/6/202413:00BWBausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel..
03/6/202413:00BWBausch + Lomb Launches Blink™ NutriTears® Clinically Proven..
29/5/202422:44EDGAR2Form 8-K - Current report
29/5/202422:30BWBausch + Lomb Announces 2024 Annual Meeting of Shareholder..
28/5/202415:00BWBausch + Lomb Announces Presentation of New Scientific Data..
28/5/202412:59BWBausch + Lomb Receives Health Canada Approval for enVista®..
07/5/202415:09IHMARKETNEWSFutures Pointing To Roughly Flat Open On Wall Street
06/5/202422:34IHMARKETNEWSU.S. Stocks See Further Upside Amid Renewed Interest Rate..
01/5/202412:58BWBausch + Lomb Announces First-Quarter 2024 Results
29/4/202413:00BWBausch + Lomb Announces Presentation of New Data at the..
Apertura: 15,35 Min: 15,26 Max: 15,52
Chiusura: 15,35

La tua Cronologia

NYSE
BLCO
Bausch plus Lomb
AMEX
RSPD
Invesco S&P 500 Equal We...
AMEX
BALT
Innovator Defined Wealth...
TG
A2E4CQ
Aareal Bank
TG
A1ZXJW
At & T
NYSE
GBCI
Glacier Bancorp
AMEX
KARS
Kraneshares Electric Veh...
ASX
LITCF
Lithium Australia NL
TG
KDB
KBC Groep NV
TG
TPO
Tokyo Electric Power
NYSE
HCHC
HC2
ASX
VORDB
Vortiv
AMEX
GSEW
Goldman Sachs Equal Weig...
AMEX
INVN
Alger Russell Innovation...
TSXV
FMAN
Freeman Gold
TG
BLB6J4
Bavarian State Bank
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci